ECTRIMS 2024: Autologous Hematopoietic Stem Cell Transplant Tied to Clinical Stability in Patients With MS Over Four Years
Findings show effectiveness even in real-world patients with high baseline disability, progressive disease forms
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.